Encompass Health Corporation

57.39+2.67+4.88%Vol 2.11M1Y Perf -31.57%
Jun 24th, 2022 16:00 DELAYED
BID57.07 ASK57.60
Open55.44 Previous Close54.72
Pre-Market- After-Market57.39
 - -  - -%
Target Price
83.44 
Analyst Rating
Strong Buy 1.10
Potential %
45.39 
Finscreener Ranking
★★★+     51.76
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★+     53.70
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★+     49.62
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
★★     40.07
Price Range Ratio 52W %
13.33 
Earnings Rating
Sell
Market Cap5.73B 
Earnings Date
26th Jul 2022
Alpha0.00 Standard Deviation0.09
Beta0.95 

Today's Price Range

55.1157.43

52W Range

53.0385.75

5 Year PE Ratio Range

13.3031.50

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
1.74%
1 Month
-10.31%
3 Months
-15.48%
6 Months
-10.48%
1 Year
-31.57%
3 Years
-7.75%
5 Years
21.14%
10 Years
195.80%

TickerPriceChg.Chg.%
EHC57.392.67004.88
AAPL141.663.39002.45
GOOG2 370.76117.07005.19
MSFT267.708.84003.41
XOM86.901.69001.98
WFC40.762.86007.55
JNJ182.292.63001.46
FB196.640.99000.51
GE67.083.01004.70
JPM117.323.40002.98
Financial StrengthValueIndustryS&P 500US Markets
1.00
1.30
0.63
1.78
4.90
Leverage Ratio 3.60
ProfitabilityValueIndustryS&P 500US Markets
95.90
15.20
20.20
12.00
9.45
RevenueValueIndustryS&P 500US Markets
5.22B
52.35
4.98
6.28
DividendsValueIndustryS&P 500US Markets
1.99
1.12
11.18
11.65
Payout ratio29.00
Earnings HistoryEstimateReportedSurprise %
Q01 20220.930.974.30
Q04 20211.060.97-8.49
Q03 20211.071.03-3.74
Q02 20211.011.1715.84
Q01 20210.801.0531.25
Q04 20200.860.938.14
Q03 20200.750.784.00
Q02 20200.390.31-20.51
Earnings Per EndEstimateRevision %Trend
6/2022 QR0.98-3.92Negative
9/2022 QR1.01-0.98Negative
12/2022 FY4.09-0.49Negative
12/2023 FY4.540.89Positive
Next Report Date26th Jul 2022
Estimated EPS Next Report0.98
Estimates Count6
EPS Growth Next 5 Years %7.30
Volume Overview
Volume2.11M
Shares Outstanding99.80K
Shares Float76.55M
Trades Count19.38K
Dollar Volume119.93M
Avg. Volume1.01M
Avg. Weekly Volume1.43M
Avg. Monthly Volume874.30K
Avg. Quarterly Volume712.69K

Encompass Health Corporation (NYSE: EHC) stock closed at 57.39 per share at the end of the most recent trading day (a 4.88% change compared to the prior day closing price) with a volume of 2.11M shares and market capitalization of 5.73B. Is a component of Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 43178 people. Encompass Health Corporation CEO is Mark J. Tarr.

The one-year performance of Encompass Health Corporation stock is -31.57%, while year-to-date (YTD) performance is -12.06%. EHC stock has a five-year performance of 21.14%. Its 52-week range is between 53.03 and 85.745, which gives EHC stock a 52-week price range ratio of 13.33%

Encompass Health Corporation currently has a PE ratio of 14.40, a price-to-book (PB) ratio of 2.85, a price-to-sale (PS) ratio of 1.08, a price to cashflow ratio of 7.30, a PEG ratio of 2.32, a ROA of 5.96%, a ROC of 9.67% and a ROE of 22.10%. The company’s profit margin is 9.45%, its EBITDA margin is 20.20%, and its revenue ttm is $5.22 Billion , which makes it $52.35 revenue per share.

Of the last four earnings reports from Encompass Health Corporation, there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $0.98 for the next earnings report. Encompass Health Corporation’s next earnings report date is 26th Jul 2022.

The consensus rating of Wall Street analysts for Encompass Health Corporation is Strong Buy (1.1), with a target price of $83.44, which is +45.39% compared to the current price. The earnings rating for Encompass Health Corporation stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Encompass Health Corporation has a dividend yield of 1.99% with a dividend per share of $1.12 and a payout ratio of 29.00%.

Encompass Health Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 6.42, ATR14 : 1.97, CCI20 : -48.81, Chaikin Money Flow : -0.03, MACD : -2.68, Money Flow Index : 44.90, ROC : -6.49, RSI : 42.44, STOCH (14,3) : 33.88, STOCH RSI : 1.00, UO : 52.10, Williams %R : -66.12), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Encompass Health Corporation in the last 12-months were: Douglas E. Coltharp (Option Excercise at a value of $549 295)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
9 (90.00 %)
9 (90.00 %)
9 (90.00 %)
Moderate Buy
1 (10.00 %)
1 (10.00 %)
1 (10.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.10
Strong Buy
1.10
Strong Buy
1.10

Encompass Health Corporation

Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. It operates in two segments: inpatient rehabilitation and home health and hospice. The Inpatient rehabilitation segment contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas. The Home health and hospital segment provides skilled home health services through agencies concentrated in the southeastern United States and Texas, which include nursing, physical, occupational, and speech therapy, social work, and hospice services.

CEO: Mark J. Tarr

Telephone: +1 205 967-7116

Address: 9001 Liberty Parkway, Birmingham 35242, AL, US

Number of employees: 43 178

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

65%35%

Bearish Bullish

54%46%

Bearish Bullish

52%48%

News

Stocktwits